Return on Assets (ROA): 10.14%
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 10.14% is 98% above its 5-year average of 5.11%, near the high end of its 5-year range (0.20%–13.55%).
As of Thursday, June 25, 2026. 4.79% below its 12-month average of 10.65%.
PODD Return on Assets (ROA) Chart
Annual fiscal-year return on assets; no daily interpolation.
PODD Average Return on Assets (ROA) Chart
PODD Current vs Average Return on Assets (ROA) Chart
PODD Return on Assets (ROA) Metrics
RETURN ON ASSETS (ROA)
10.14%
RETURN ON ASSETS (ROA) AVG TTM
10.65%
RETURN ON ASSETS (ROA) AVG 3Y
7.37%
RETURN ON ASSETS (ROA) AVG 5Y
5.11%
RETURN ON ASSETS (ROA) AVG 10Y
-0.39%
RETURN ON ASSETS (ROA) AVG 15Y
-8.10%
RETURN ON ASSETS (ROA) AVG 20Y
-18.24%
CURRENT VS TTM AVG
-4.79%
CURRENT VS 3Y AVG
+37.63%
CURRENT VS 5Y AVG
+98.50%
CURRENT VS 10Y AVG
+2681.94%
CURRENT VS 15Y AVG
+225.19%
CURRENT VS 20Y AVG
+155.60%
PODD Competitors' Return on Assets (ROA)
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Insulet Corp. (PODD) | $10.31B | 10.14% | 10.65% | 7.37% | 5.11% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Baxter International Inc. (BAX)vs › | $10.87B | -5.53% | -3.64% | -1.62% | 0.47% |
| Charles River Laboratories International, Inc. (CRL)vs › | $9.73B | -2.39% | -0.94% | 2.58% | 3.75% |
| Henry Schein, Inc. (HSIC)vs › | $9.55B | 3.49% | 3.68% | 4.39% | 5.01% |
| Revvity, Inc. (RVTY)vs › | $11.78B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.24B | 6.81% | 6.68% | 6.69% | 12.75% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $7.57B | 1.72% | -6.26% | -11.14% | 1.46% |
| Oscar Health, Inc. (OSCR)vs › | $7.56B | -0.42% | -3.24% | -6.85% | -10.42% |
| Solventum Corporation (SOLV)vs › | $13.09B | 10.16% | 7.10% | 8.43% | 7.35% |
Asset Efficiency
ROA
10.1%
ROE
23.3%
Return on Assets (ROA) Formula & Definition
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Assets (ROA) FAQ
- What is the return on assets (ROA) for Insulet Corp. (PODD)?
- The return on assets (ROA) for PODD stock is 10.14%.
- Is Insulet Corp.'s return on assets (ROA) high or low?
- The return on assets (ROA) of 10.14% is 98% above its 5-year average of 5.11%, near the high end of its 5-year range (0.20%–13.55%).
- What is the TTM average return on assets (ROA) for Insulet Corp. (PODD)?
- The TTM average return on assets (ROA) for PODD stock is 10.65%.
- What is the 3Y average return on assets (ROA) for Insulet Corp. (PODD)?
- The 3Y average return on assets (ROA) for PODD stock is 7.37%.
- What is the 5Y average return on assets (ROA) for Insulet Corp. (PODD)?
- The 5Y average return on assets (ROA) for PODD stock is 5.11%.
- What is the 10Y average return on assets (ROA) for Insulet Corp. (PODD)?
- The 10Y average return on assets (ROA) for PODD stock is -0.39%.
- What is the 15Y average return on assets (ROA) for Insulet Corp. (PODD)?
- The 15Y average return on assets (ROA) for PODD stock is -8.10%.
- What is the 20Y average return on assets (ROA) for Insulet Corp. (PODD)?
- The 20Y average return on assets (ROA) for PODD stock is -18.24%.
PODD Return on Assets (ROA) History
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 7.75% |
| 2024-12-31 | 13.55% |
| 2023-12-31 | 7.97% |
| 2022-12-31 | 0.20% |
| 2021-12-31 | 0.82% |
| 2020-12-31 | 0.36% |
| 2019-12-31 | 1.01% |
| 2018-12-31 | 0.35% |
| 2017-12-31 | -3.29% |
| 2016-12-31 | -6.32% |
| 2015-12-31 | -26.72% |
| 2014-12-31 | -17.04% |
| 2013-12-31 | -15.62% |
| 2012-12-31 | -26.19% |
| 2011-12-31 | -27.28% |
| 2010-12-31 | -39.15% |
| 2009-12-31 | -46.34% |
| 2008-12-31 | -84.95% |
| 2007-12-31 | -40.95% |
| 2006-12-31 | -62.92% |
| 2005-12-31 | -128.85% |
| 2004-12-31 | -50.96% |
| 2003-12-31 | -240.84% |
| 2002-12-31 | -71.84% |
Related Metrics
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Ashley A. McEvoy